MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 108 filers reported holding MAXCYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $102,841 | +1.1% | 26,235 | +8.0% | 0.00% | 0.0% |
Q1 2024 | $101,754 | -12.0% | 24,285 | -1.3% | 0.00% | 0.0% |
Q4 2023 | $115,644 | +48.5% | 24,605 | -1.4% | 0.00% | 0.0% |
Q3 2023 | $77,875 | -30.9% | 24,960 | +1.6% | 0.00% | 0.0% |
Q2 2023 | $112,767 | +10.1% | 24,568 | +18.7% | 0.00% | 0.0% |
Q1 2023 | $102,455 | -6.6% | 20,698 | +3.0% | 0.00% | 0.0% |
Q4 2022 | $109,708 | -12.9% | 20,093 | +4.0% | 0.00% | 0.0% |
Q3 2022 | $126,000 | +38.5% | 19,315 | +0.3% | 0.00% | 0.0% |
Q2 2022 | $91,000 | -26.6% | 19,256 | +8.7% | 0.00% | 0.0% |
Q1 2022 | $124,000 | -30.7% | 17,718 | +0.9% | 0.00% | 0.0% |
Q4 2021 | $179,000 | – | 17,566 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |